Cedara prepares Asian initiative

Article

B-Soft Group, a leading vendor of HIS products in China, has signed with Canadian PACS developer Cedara to sell that company's PACS products. Under an agreement signed Nov. 5, B-Soft and Cedara will cooperatively develop an integrated hospital

B-Soft Group, a leading vendor of HIS products in China, has signed with Canadian PACS developer Cedara to sell that company's PACS products. Under an agreement signed Nov. 5, B-Soft and Cedara will cooperatively develop an integrated hospital information and image management system that provides a complete solution tailored to workflow in Chinese hospitals. The deal is a milestone in Cedara's strategic plans to expand business in China.

Other efforts include a cooperative agreement signed in late November with Hong Kong Polytechnic University to deploy Cedara's PACS. The university is expected to provide Cedara with a clinical environment where it can display its technology to potential customers, offer training, and learn more about regional workflow requirements. Funding from the Canadian International Development Agency will help defray costs of penetrating the Chinese market, providing some 80% of the expense of developing a business plan for the development of Chinese medical IT products and services.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.